The major genetic pathways of CRC are the inactivation/mutation of the tumor suppressor genes APC and TP53 and activation/mutation of the oncogene KRAS that are required for tumor initiation and progression of CRC [37–39]. The gene discussed is TP53; the disease is neoplasm.